BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City as follows:
|Date:||Tuesday, September 26, 2023|
To schedule a 1×1 meeting with the Company, please contact firstname.lastname@example.org.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
Lisa M. Wilson, In-Site Communications, Inc.
Source: ANI Pharmaceuticals, Inc.
- Lawsuit Oct. 20 Deadline Notice: Investors who lost over $100,000 with shares of Comerica Incorporated (NYSE: CMA) between February 2021 and May 2023 should contact the Shareholders Foundation - October 2, 2023
- A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients - October 2, 2023
- DAV launches new Caregiver Support Program - October 2, 2023